Beylikdüzü State Hospital
Istanbul, Beylikdüzü, 34147, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT06658886
The aim of this study is to compare the efficacy of paraffin therapy, a physical therapy modality, and ultrasound-guided corticosteroid injection in the treatment of carpal tunnel syndrome, the most common entrapment neuropathy. By doing so, the study will evaluate the effectiveness and feasibility of these two alternative, low-side-effect treatments for managing this frequently encountered condition.
Interested in participating?
Request Info18 year–65 year
All sexes
Observational
Istanbul, Beylikdüzü, 34147, Turkey (Türkiye)
Location status: Recruiting
A total of 46 patients, aged 18-65, diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies, will be included in the study.Pain levels will be assessed using the Visual Analog Scale (VAS), and functional impairment will be measured with the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Electrophysiological evaluations will be performed by a neurology specialist at the 1st and 3rd month follow-ups outside of working hours and without being billed to the Social Security Institution (SGK). VAS, BCTQ scores, and electrophysiological parameters will be evaluated at baseline, and at the 4th and 12th-week follow-ups post-treatment. Electrophysiological measurements will include median nerve distal motor latency (MMNDL), median nerve distal sensory latency (MNSDL), sensory nerve conduction velocity (SNCV), compound muscle action potential (CMAP), and sensory nerve action potential (SNAP) amplitudes.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention
Time frame: 0 day, 4th week and 12th week
The VAS will be used to measure pain intensity. Patients will mark their pain level on a 10 cm scale, where 0 represents "no pain" and 10 represents the "worst imaginable pain." This will be evaluated at baseline, and at the 4th and 12th weeks post-treatment.
Time frame: 0 day, 4th week and 12th week
The SSS assesses the severity of carpal tunnel symptoms such as pain, tingling, and numbness. The total score for this scale ranges from a minimum of 11 to a maximum of 55. A lower score indicates mild or no symptoms, while a higher score suggests more severe symptoms. As the score increases, the severity of symptoms worsens, with a score closer to 55 reflecting a significantly greater impact on daily life.
Time frame: 0 day, 4th week and 12th week
The SSS assesses the severity of carpal tunnel symptoms such as pain, tingling, and numbness. The total score for this scale ranges from a minimum of 11 to a maximum of 55. A lower score indicates mild or no symptoms, while a higher score suggests more severe symptoms. As the score increases, the severity of symptoms worsens, with a score closer to 55 reflecting a significantly greater impact on daily life.
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Time frame: 0 day, 4th week and 12th week
It is a finding from electrophysiological evaluation
Contact information is provided by the study sponsor or research team.
Büşra Şirin Ahısha
CONTACT
Büşra Şirin Ahısha, MD
CONTACT
Beylikduzu State Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07660913
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Izmir, Turkey (Türkiye)
View Trial DetailsNCT07614425
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Helsinki, Finland
View Trial DetailsNCT06239259
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Bangkok Noi, Bangkok, Thailand
View Trial DetailsNCT07324005
Carpal Tunnel Release, Carpal Tunnel Syndrome
Taipei, Taiwan
View Trial Details